Kouchoukos, N.T., Kirklin, J.W., Ebstein anomaly (2013) Cardiac Surgery: Morphology, Diagnostic Criteria, Natural History, Techniques, Results, and Indications, pp. 1576-1598., In, Kouchoukos NT, Blackstone EH, Hanley FL, eds., 4th ed, Philadelphia, PA, Elsevier/Saunders Repositorio EdocUR-U. Rosario Universidad del Rosario instacron:Universidad del Rosario Repositorio U. El Bosque Universidad El Bosque instacron:Universidad El Bosque
1. Pope HJ, Aufderheide TP, Ruthazer R, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 2000;342:1163-70. 2. GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82. 3. Centers for Disease Control and Prevention, National Center for Health Statistics. Compressed Mortality File 1999-2007. CDC WONDER Database, compiled from Compressed Mortality File 1999-2007 Series 20 No. 2K, 2008. Accessed on: http://wonder.cdc.gov/cmf-icd10.html on Feb 20, 2011. 4. Zipes DP, Wellens HJJ. Sudden cardiac death. Circulation 1998;98:2334-51. 5. Bertrand ME, Simoons ML, Fox KAA, et al. Management of acute coronary syndromes: Acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 2000;21:1406-32. 6. Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation 2007;116:2634-53. 7. Anderson JL, Adams CD, Antman EM, et al: ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): Developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 2007; 116:e148. 8. Antman EM, Anbe DT, Armstrong PW, et al: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004; 110:e82. 9. Blomkalns AL, Gibler WB: Chest pain unit concept: rationale and diagnostic strategies. Cardiol Clin 2005; 23:411. 11. Morrow DA, Cannon CP, Jesse RL, et al: National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 2007; 115:e356. 12. Wu AH, Jaffe AS, Apple FS, et al: National Academy of Clinical Biochemistry laboratory medicine practice guidelines: Use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem 2007; 53:2086. 13. Keller T, Zeller T, Peetz D, et al: Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009; 61:868. 14. Puleo PR, Meyer D, Watchen C, et al. Use of a rapid assay of subforms of creatine kinase MB to diagnose to rule out acute myocardial infarctation. N Engl J Med 1994;331:561-66. 15. Fesmire FM, Christenson RH, Fody EP, et al. Delta creatine kinase-MB outperforms myoglobin at two hours during the emergency department identification and exclusion of troponin positive non-ST-segment elevation acute coronary syndromes. Ann Emerg Med 2004;44:12-9. 16. Ghani F, Wu AH, Graff L, et al. Role of heart-type fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem 2000;46:718-9. 17. Ruzgar O, Bilge AK et al. The use of human heart-type fatty acid-binding protein as an early diagnostic biochemical marker of myocardial necrosis in patients with acute coronary syndrome, and its comparison with troponin-T and creatine kinase–myocardial band. Heart Vessels 2006;21:309–14. 18. Bhagavan NV, Ha JS, Park JH, et al. Utility of serum Fatty Acid concentrations as a marker for acute myocardial infarction and their potential role in the formation of ischemia-modified albumin: a pilot study. Clin Chem. 2009;55:1588-90. 19. Seino Y, Ogata K, Takano T, et al. Use of a whole blood rapid panel test for heart-type fatty acid-binding protein in patients with acute chest pain: comparison with rapid troponin T and myoglobin tests. Am J Med 2003;115:185-90. 20. Bruins Slot MH, van der Heijden GJ, Rutten FH, et al. Heart-type Fatty acid-binding protein in Acute Myocardial infarction Evaluation (FAME): background and design of a diagnostic study in primary care. BMC Cardiovasc Disord 2008;8:8-13 21. Tong CY, Chan CP, Cheung KY et al. A point-of-care immunotest for bedside determination of heart-type fatty acid-binding protein. Analytical Letters 2010;43:735-44. 22. Kabekkodu S, Mananje S, Saya R. A study on the role of heart type fatty acid binding protein in the diagnosis of acute myocardial infarction. Journal of Clinical and Diagnostic Research 2016;10: 7 – 10. 23. Pyati A, Devaranavadagi B, Sajjannar S, et al. Heart Type Fatty Acid Binding Protein: A better cardiac biomarker than CK – MB and myoglobin in the early diagnosis of acute myocardial infarction. Journal of Clinical and Diagnostic Research 2015;9: 8 – 11. 24. Reiter M, Twerenbold R, Reichlin T, et al. Heart type fatty acid binding protein in the early diagnosis of acute myocardial infarction. Heart 2013;99:708-714. 25. Schoenenberger A, Stallone F, Walz B, et al. Incremental value of heart type fatty acid binding protein in suspected acute myocardial infarction early after symptoms onset. Eur Heart J Acute Cardiovasc Care 2016;5(2):185-92. 26. Danese E, Montagnana M. An historical approach to the diagnostic biomarkers of acute coronary syndrome. Am Transl Med 2016;4(10): 1 – 11. 27. Ladue JS, Wröblewski F, Karmen A. Serum glutamic oxaloacetic transaminase activity in human acute myocardial infarction. Science 1954; 120:497 – 9. 28. Ulmer DD, Valle BL, Wacker WE. Metalloenzymes and myocardial infarction. Malic an lactic dehydrogenase activities and zinc concentrations in serum. N Engl J Med 1956;255:450 – 6. 29. Dreyfus JC, Schapira G, Rasnais J, et al. Serum creatine kinase in the diagnosis of myocardial infarct. Rev Fr Etud Clin Biol 1960;5: 386-7. 30. Giannitsis E, Kurz K, Hallermayer K, et al. Analytical validation of a high sensitivity cardiac troponin T assay. Clin Chem 2010;56:254 – 61. Repositorio EdocUR-U. Rosario Universidad del Rosario instacron:Universidad del Rosario
Dennis, R. Comparación de las pruebas de función pulmonar de pacientes con DM tipo 2 sometidos a tratamiento con insulina inyectada vs tratamiento con hipoglucemiantes orales. Acta Médica Colombiana 2010; 35: 113-118 Dennis, R. Inadequate glucose control in type 2 diabetes is associated with impaired lung function and, systemic inflamation: a cross-sectional study. BMC Pulmonary Medicine 2010; 10: 38. Kim, H. J. The impact of insulin sensitisers on lung function in patients with chronic obstructive pulmonary disease and diabetes. Int J Tuber Lung Dis 2010; 14(3):362–367 Klein, O. Review Article, Systematic review of the association between lung function and Type 2 diabetes mellitus. Diabet. Med. 27, 977–987 (2010) Repositorio EdocUR-U. Rosario Universidad del Rosario instacron:Universidad del Rosario